These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 23298941

  • 21. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec 01; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract] [Full Text] [Related]

  • 22. Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT.
    Khoo TL, Catalano A, Supple S, Chong L, Yeoh SC, Yeung S, Iland H.
    Leuk Lymphoma; 2013 Jan 01; 54(1):186-8. PubMed ID: 22712835
    [No Abstract] [Full Text] [Related]

  • 23. Pityriasis rosea associated with imatinib (STI571, Gleevec).
    Konstantopoulos K, Papadogianni A, Dimopoulou M, Kourelis C, Meletis J.
    Dermatology; 2002 Jan 01; 205(2):172-3. PubMed ID: 12218236
    [Abstract] [Full Text] [Related]

  • 24. Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
    Ostro D, Lipton J.
    Leuk Lymphoma; 2007 Jan 01; 48(1):195-6. PubMed ID: 17325868
    [No Abstract] [Full Text] [Related]

  • 25. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
    Kong JH, Yoo SH, Lee KE, Nam SH, Kwon JM, Lee SM, Chang HJ, Choi MY, Cho MS, Mun YC, Nam E, Lee SN, Seong CM.
    Acta Haematol; 2007 Jan 01; 118(4):205-8. PubMed ID: 18030002
    [Abstract] [Full Text] [Related]

  • 26. [Chronic myeloid leukemia treatment and human immunodeficiency virus infection].
    Campillo-Recio D, Perez-Rodriguez L, Yebra E, Cervero-Jimenez M.
    Rev Clin Esp (Barc); 2014 May 01; 214(4):231-2. PubMed ID: 24564991
    [No Abstract] [Full Text] [Related]

  • 27. Skin fragility and blistering with imatinib mesylate.
    Verma SM, Murphy G.
    J Eur Acad Dermatol Venereol; 2010 Apr 01; 24(4):496-8. PubMed ID: 19925597
    [No Abstract] [Full Text] [Related]

  • 28. Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.
    Mabed M, Elhefni AM, Damnhouri G.
    Leuk Lymphoma; 2012 Nov 01; 53(11):2310-1. PubMed ID: 22462614
    [No Abstract] [Full Text] [Related]

  • 29. Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty.
    Giona F, Mariani S, Gnessi L, Moleti ML, Rea M, De Vellis A, Marzella D, Testi AM, Foà R.
    Haematologica; 2013 Mar 01; 98(3):e25-7. PubMed ID: 22983586
    [No Abstract] [Full Text] [Related]

  • 30. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
    Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM.
    Indian J Dermatol Venereol Leprol; 2006 Mar 01; 72(1):63-4. PubMed ID: 16481719
    [No Abstract] [Full Text] [Related]

  • 31. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
    Govind Babu K, Attili VS, Bapsy PP, Anupama G.
    Int Ophthalmol; 2007 Feb 01; 27(1):43-4. PubMed ID: 17410337
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Imatinib-induced Stevens-Johnsons syndrome.
    Jha P, Himanshu D, Jain N, Singh AK.
    BMJ Case Rep; 2013 Jan 23; 2013():. PubMed ID: 23349042
    [Abstract] [Full Text] [Related]

  • 35. Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
    Murphy M, Close J, Lottenberg R, Rajasekhar A.
    Am J Med Sci; 2014 Mar 23; 347(3):254-5. PubMed ID: 24553361
    [No Abstract] [Full Text] [Related]

  • 36. Leukemia. Q&A highlights.
    Frame D, Sessions J, Fausel C.
    Am J Health Syst Pharm; 2007 Dec 15; 64(24 Suppl 15):S22. PubMed ID: 18056929
    [No Abstract] [Full Text] [Related]

  • 37. Gleevec: tailoring to fit.
    May TS.
    Drug Discov Today; 2003 Mar 01; 8(5):188-9. PubMed ID: 12634004
    [No Abstract] [Full Text] [Related]

  • 38. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients.
    Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P, Tulliez M, Giraudier S.
    J Am Acad Dermatol; 2003 Feb 01; 48(2):201-6. PubMed ID: 12582389
    [Abstract] [Full Text] [Related]

  • 39. [Imatinib mesylate-induced acute cytolytic hepatitis].
    Rocca P, El Jastimi S, Troncy J, Scoazec JY, Boucher A, Vial T, Trépo C, Zoulim F.
    Gastroenterol Clin Biol; 2004 Oct 01; 28(10 Pt 1):918-9. PubMed ID: 15523233
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.